Johnson and Johnson’s new diabetes drug causes vaginal yeast infections and other unlabeled health conditions

The FDA has recently approved Johnson and Johnson’s new type 2 diabetes drug Invokana. This drug, although deemed safe by the government, has been found to cause debilitating side effects including Candida yeast infections and a host of unlabeled risks. An advisory…